These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34286397)

  • 1. Omega 3 fatty acids effect on the vascular calcification biomarkers fetuin A and osteoprotegerin in hemodialysis patients.
    Werida RH; Abou-Madawy S; Abdelsalam M; Helmy MW
    Clin Exp Med; 2022 May; 22(2):301-310. PubMed ID: 34286397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients.
    An WS; Lee SM; Son YK; Kim SE; Kim KH; Han JY; Bae HR; Rha SH; Park Y
    Nutr Res; 2012 Jul; 32(7):495-502. PubMed ID: 22901557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of vascular calcification and mortality in patients with ESRD.
    Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
    Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L
    Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.
    Alshahawey M; El Borolossy R; El Wakeel L; Elsaid T; Sabri NA
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):626-633. PubMed ID: 33594986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients.
    Lee JE; Kim HJ; Moon SJ; Nam JS; Kim JK; Kim SK; Yun GY; Ha SK; Park HC
    Korean J Intern Med; 2013 Nov; 28(6):668-77. PubMed ID: 24307842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.
    Pateinakis P; Papagianni A; Douma S; Efstratiadis G; Memmos D
    BMC Nephrol; 2013 Jun; 14():122. PubMed ID: 23758931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients.
    Talib A; Nakagawa N; Saito E; Matsuki M; Kobayashi M; Akasaka K; Hirayama T; Ishida H; Sato N; Hasebe N
    Hypertens Res; 2012 Apr; 35(4):426-33. PubMed ID: 22129515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of fetuin-A in vascular calcification in children with chronic kidney disease.
    Makulska I; Szczepańska M; Drożdż D; Polak-Jonkisz D; Zwolińska D
    Adv Clin Exp Med; 2019 Apr; 28(4):499-505. PubMed ID: 30070080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Correlation Between Circulating Fetuin-A and Pentraxin-3 With Biochemical Parameters of Calcification in Hemodialysis Patients.
    Hashemi J; Joshaghani HR; Akaberi A; Hesari Z; Ghanbari R; Mohammadzadeh M; Golshan AR
    Arch Iran Med; 2017 Dec; 20(12):752-755. PubMed ID: 29664315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients.
    Kim HR; Kim SH; Han MJ; Yoon YS; Oh DJ
    Nephron Clin Pract; 2013; 123(3-4):165-72. PubMed ID: 23921088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients.
    Lin HH; Liou HH; Wu MS; Huang CC
    BMC Nephrol; 2016 Mar; 17():33. PubMed ID: 27007989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.
    Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H
    Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetuin-A as a risk factor for mortality in hemodialysis patients.
    Pecovnik Balon B; Knehtl M; Bevc S; Jakopin E; Gorenjak M
    Wien Klin Wochenschr; 2010 May; 122 Suppl 2():63-7. PubMed ID: 20517675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Calcification Markers and Hemodialysis Vascular Access Complications.
    Lyu B; Banerjee T; Scialla JJ; Shafi T; Yevzlin AS; Powe NR; Parekh RS; Astor BC
    Am J Nephrol; 2018; 48(5):330-338. PubMed ID: 30380526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of coronary calcification in Indian hemodialysis patients.
    Jasani R; Hase N; Kumar R; Dedhia P; Jamale T; Bajpai D
    Saudi J Kidney Dis Transpl; 2018; 29(4):822-827. PubMed ID: 30152418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of vascular calcification in elderly hemodialysis patients.
    Osorio A; Ortega E; Torres JM; Sanchez P; Ruiz-Requena E
    Mol Cell Biochem; 2013 Feb; 374(1-2):21-7. PubMed ID: 23124853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function.
    Collado S; Coll E; Nicolau C; Azqueta M; Pons M; Cruzado JM; de la Torre B; Deulofeu R; Mojal S; Pascual J; Cases A
    BMC Nephrol; 2017 Sep; 18(1):290. PubMed ID: 28882110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors Associated With Altered Circulating Micro RNA -125b and Their Influences on Uremic Vascular Calcification Among Patients With End-Stage Renal Disease.
    Chao CT; Yuan TH; Yeh HY; Chen HY; Huang JW; Chen HW
    J Am Heart Assoc; 2019 Jan; 8(2):e010805. PubMed ID: 30646802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
    Nitta K; Akiba T; Uchida K; Kawashima A; Yumura W; Kabaya T; Nihei H
    Am J Kidney Dis; 2003 Aug; 42(2):303-9. PubMed ID: 12900812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.